Publication: The impact of active nutritional support for head and neck cancer patients receiving concurrent chemoradiotherapy
Issued Date
2020-01-01
Resource Type
ISSN
22288082
Other identifier(s)
2-s2.0-85079149685
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Siriraj Medical Journal. Vol.72, No.1 (2020), 47-58
Suggested Citation
Vutisiri Veerasarn, Nattapatch Janhom, Yaowalak Chansilpa, Nan Suntornpong, Kullathorn Thephamongkhol, Nantakan Apiwarodom, Janjira Petsuksiri, Pittaya Dankulchai, Jiraporn Setakornnukul, Achiraya Teyateeti, Warissara Rongthong, Panidz Chaysiri The impact of active nutritional support for head and neck cancer patients receiving concurrent chemoradiotherapy. Siriraj Medical Journal. Vol.72, No.1 (2020), 47-58. doi:10.33192/Smj.2020.07 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/53844
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The impact of active nutritional support for head and neck cancer patients receiving concurrent chemoradiotherapy
Other Contributor(s)
Abstract
© 2020 Faculty of Medicine Siriraj Hospital, Mahidol University. Objective: Malnutrition is the most common problem in head and neck cancer (HNC) patients receiving concurrent chemoradiotherapy. The radiation toxicities cause decreased food intake, with resultant severe weight loss and malnutrition. This study sought to determine whether an active nutrition improvement counseling program before and during concurrentchemoradiotherapy for HNC patients could increase the treatment completion rate without the interruptions caused by the side effects of chemoradiotherapy. Methods: The findings of a prospective study of the effects of an active nutrition improvement program before and during concurrent chemoradiotherapy (study, n = 32) was compared with those of a retrospective chart review of HNC patients who had received definite or postoperative concurrent chemoradiotherapy (control, n = 80). The correlations between nutritional status and the number of treatment completions, number of tube feeding insertions during treatment, RTOG toxicity, nutritional status, and quality of life were obtained. Results: There was no statistically significant difference between the concurrent chemoradiotherapy completion rates of both groups (p = 0.121; 95% CI, 0.226-1.188). The major cause of delayed or discontinued chemotherapy was oral mucositis. No significant differences were found in the tube feeding insertion rates and RTOG toxicities of both groups. However, the data showed a clinicallysignificant difference in the concurrent chemoradiotherapy completion rate for the study group (56%), more than 15 percentage points higher than the control group's rate (40%). Conclusion: An active nutrition improvement program before and during concurrent chemoradiotherapy is clinically beneficial for HNC patients, providing a higher treatment completion rate than otherwise.